AAG
HALO icon

Armstrong Advisory Group’s Halozyme HALO Stock Holding History

Armstrong Advisory Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Hold
300
– – ﹤0.01% 564
2026
Q1 		$19.4K Hold
300
– – ﹤0.01% 573
2025
Q4 		$20.2K Hold
300
– – ﹤0.01% 559
2025
Q3 		$22K Hold
300
– – ﹤0.01% 541
2025
Q2 		$15.6K Buy
300
+200
+200% +$11.4K ﹤0.01% 580
2025
Q1 		$4.78K Hold
100
– – ﹤0.01% 700
2024
Q4 		$4.78K Hold
100
– – ﹤0.01% 700
2024
Q3 		$5.72K Buy
+100
New +$5.73K ﹤0.01% 650

Other funds holding HALO

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAM
Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return
CI
Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Armstrong Advisory Group's HALO Position: Q2 2026 in Review

Armstrong Advisory Group held its Halozyme (HALO) position steady in Q2 2026 at 300 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Armstrong Advisory Group first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. 84 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Armstrong Advisory Group held 300 shares of Halozyme worth $23.5K as of Q2 2026.
  • Armstrong Advisory Group left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #564 holding.
  • Armstrong Advisory Group first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
  • 84 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.